美国白宫：美国总统特朗普下令环保局加快建设用于生产处方药、活性药物成分及其他必要原材料的设施。

Core Viewpoint - The U.S. government, under President Trump, has directed the Environmental Protection Agency (EPA) to expedite the construction of facilities for the production of prescription drugs, active pharmaceutical ingredients, and other essential raw materials [1] Group 1 - The initiative aims to enhance domestic production capabilities for critical medical supplies [1] - This move is part of a broader strategy to reduce reliance on foreign sources for pharmaceuticals [1] - The focus on active pharmaceutical ingredients indicates a significant shift towards strengthening the U.S. pharmaceutical supply chain [1]